| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia
|
Oda, Shannon K.
|
|
|
130 |
22 |
p. 2410-2419
|
artikel
|
| 2 |
Advances in the diagnosis and treatment of Von Willebrand disease
|
Sharma, Ruchika
|
|
|
130 |
22 |
p. 2386-2391
|
artikel
|
| 3 |
Analysis of ITGB2 rare germ line variants in chronic lymphocytic leukemia
|
Tiao, Grace
|
|
|
130 |
22 |
p. 2443-2444
|
artikel
|
| 4 |
Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11
|
Zhen, Tao
|
|
|
130 |
22 |
p. 2431-2442
|
artikel
|
| 5 |
Clonality in context: hematopoietic clones in their marrow environment
|
Cooper, James N.
|
|
|
130 |
22 |
p. 2363-2372
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
130 |
22 |
p. i
|
artikel
|
| 7 |
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
|
Kumar, Shaji
|
|
|
130 |
22 |
p. 2401-2409
|
artikel
|
| 8 |
First targeted therapy in multiple myeloma
|
Kortüm, K. Martin
|
|
|
130 |
22 |
p. 2359-2360
|
artikel
|
| 9 |
Gemtuzumab ozogamicin for acute myeloid leukemia
|
Appelbaum, Frederick R.
|
|
|
130 |
22 |
p. 2373-2376
|
artikel
|
| 10 |
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
|
Moreau, Philippe
|
|
|
130 |
22 |
p. 2392-2400
|
artikel
|
| 11 |
Targeting novel mechanisms of pain in sickle cell disease
|
Tran, Huy
|
|
|
130 |
22 |
p. 2377-2385
|
artikel
|
| 12 |
The ecosystem of classical Hodgkin lymphoma
|
Steidl, Christian
|
|
|
130 |
22 |
p. 2360-2361
|
artikel
|
| 13 |
The unused iron
|
Rashidi, Armin
|
|
|
130 |
22 |
p. 2445
|
artikel
|
| 14 |
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
|
Carey, Christopher D.
|
|
|
130 |
22 |
p. 2420-2430
|
artikel
|
Tijdschrift beschrijving